A 6-month, subject-masked, randomized controlled study to assess efficacy of dexamethasone as an adjunct to bevacizumab compared with bevacizumab alone in the treatment of patients with macular edema due to central or branch retinal vein occlusion
Raj K Maturi,1,2 Vincent Chen,3 Dan Raghinaru,3 Laurie Bleau,1 Michael W Stewart4 1Midwest Eye Institute, Indianapolis, IN, USA; 2Department of Ophthalmology, Indiana University School of Medicine, Indianapolis, IN, USA; 3Jaeb Center for Health Research, Tampa, FL, USA; 4Department of Ophthalmolog...
Enregistré dans:
Auteurs principaux: | Maturi RK, Chen V, Raghinaru D, Bleau L, Stewart MW |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2014
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/cb6e9feb11294968a43238ada656744c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Intravitreal bevacizumab in macular edema secondary to branch retinal vein occlusion: 12-month results
par: Thapa R, et autres
Publié: (2012) -
Intravitreal bevacizumab for macular edema due to branch retinal vein occlusion: 12-month results
par: Demir M, et autres
Publié: (2011) -
Comparison of single injection and three monthly injections of intravitreal bevacizumab for macular edema associated with branch retinal vein occlusion
par: Ito Y, et autres
Publié: (2015) -
The comparison of intravitreal triamcinolone and bevacizumab in patients with macular edema secondary to branch retinal vein occlusion
par: Gokce G, et autres
Publié: (2014) -
Hemiretinal vein occlusion with macular hemorrhage and edema treated with intravitreal bevacizumab
par: Yalamanchi S, et autres
Publié: (2011)